Cholesterol Precursors Can Cause Developmental Defects
Main Category: CholesterolAlso Included In: Pregnancy / Obstetrics; Cleft Palate
Article Date: 05 Sep 2006 - 20:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Health Professional: | ![]() |
3.33 (3 votes) |
| Article Opinions: | 0 posts |
Although high levels of cholesterol are bad for us (putting us at increased risk of a heart attack), low levels of cholesterol can also be bad -- as a fetus, low levels of cholesterol are associated with life-long disabilities, such as learning difficulties, limb abnormalities, and cleft palate. Low levels of cholesterol during development are caused by genetic defects in the proteins that control the production of cholesterol. Therefore, these individuals not only have low levels of cholesterol but also high levels of cholesterol precursors; which of these cause the developmental defects has been a matter of debate. Now, researchers from the University of Texas Southwestern Medical Center have shown that in mice it is the high levels of cholesterol precursors that are to blame.
In their study, which appears in the September issue of the Journal of Clinical Investigation, Joseph Goldstein and colleagues found that fetal mice with normal levels of cholesterol but very high levels of cholesterol precursors had severe developmental defects, including cleft palate. Treating female mice during pregnancy with a statin (a drug that decreases the production of cholesterol) reduced the level of cholesterol precursors in the fetal mice and decreased the incidence of cleft palate. This study provides enormous insight into why certain gene defects cause disability.
In an accompanying commentary, Forbes Porter from the National Institutes of Health puts this work in context with other recent advances and outlines the work that remains before we can fully understand how high levels of cholesterol precursors cause disabilities.
TITLE: Severe facial clefting in Insig-deficient mouse embryos caused by sterol accumulation and reversed by lovaststin
AUTHOR CONTACT:
Joseph L. Goldstein
University of Texas Southwestern Medical Center, Dallas, Texas, USA.
E-mail: joe.goldstein@utsouthwestern.edu.
Michael S. Brown
University of Texas Southwestern Medical Center, Dallas, Texas, USA.
E-mail: mike.brown@utsouthwestern.edu.
View the PDF of this article at: https://www.the-jci.org/article.php?id=28988
ACCOMPANYING COMMENTARY
TITLE: Cholesterol precursors and facial clefting
AUTHOR CONTACT:
Forbes D. Porter
National Institutes of Health, Bethesda, Maryland, USA.
E-mail: fdporter@mail.nih.gov.
View the PDF of this article at: https://www.the-jci.org/article.php?id=29872
----------------------------
Article adapted by Medical News Today from original press release.
----------------------------
JCI table of contents: September 1, 2006
Contact: Karen Honey
Journal of Clinical Investigation
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |





